Press releases | WebDisclosure

Basculer en Français

9702	Companies
193438	Keywords
124688	Articles
102974	Press releases

Home
Press releases

PRESS RELEASE

published on 05/16/2025 at 14:30, 8 months 4 days ago

British Export Credit Agency Issues Expression of Interest to NioCorp for Potential Debt Guarantee of up to $200 Million for the Elk Creek Critical Minerals Project
NioCorp Developments Ltd. receives a preliminary non-binding Expression of Interest from UK Export Finance for a potential $200 million debt guarantee for the Elk Creek Critical Minerals Project. Coordination with EXIM and possible German loan guarantee

NioCorp Developments Ltd. Elk Creek Critical Minerals Project EXIM Debt Guarantee UK Export Finance
PRESS RELEASE

published on 05/16/2025 at 14:22, 8 months 4 days ago

Amundi Physical Metals plc: Final Terms
Amundi Physical Metals plc issues final terms for its ETC Securities under the Precious Metal Linked ETC Securities Programme, including details on metal entitlement, issue date, and total expense ratio

Amundi Physical Metals Plc ETC Securities Precious Metal Final Terms Metal Entitlement
PRESS RELEASE

published on 05/16/2025 at 14:07, 8 months 4 days ago

ElringKlinger: Annual General Meeting approves constant dividend and elects new Supervisory Board member
ElringKlinger AG's Annual General Meeting approves constant dividend of EUR 0.15 per share and elects new Supervisory Board member. Details of meeting outcomes and strategic outlook discussed

Annual General Meeting Dividend Supervisory Board Member ElringKlinger AG SHAPE30 Strategy
PRESS RELEASE

published on 05/16/2025 at 14:02, 8 months 4 days ago

Intershop Annual Shareholders’ Meeting: Improved financial figures and strategic course set for 2025
Intershop Communications AG conducted its Annual Shareholders’ Meeting, highlighting improved financial figures and strategic plans for 2025. Management Board discussed market trends, positive analyst ratings, and key initiatives

Financial Figures Annual Shareholders’ Meeting Intershop Communications AG B2B Commerce Strategic Plans
PRESS RELEASE

published on 05/16/2025 at 14:01, 8 months 4 days ago

Mainz Biomed Announces Interim Read Out For Its eAArly DETECT 2 Clinical Study
Mainz Biomed announces interim read out for its eAArly DETECT 2 clinical study, aiming to validate industry-leading results and support U.S. pivotal trial initiation in 2026

Clinical Study Mainz Biomed Colorectal Cancer MRNA Biomarkers EAArly DETECT 2
PRESS RELEASE

published on 05/16/2025 at 13:18, 8 months 4 days ago

technotrans Annual General Meeting: future-ready through transformation
technotrans SE Annual General Meeting approves dividend, elects new board member, and confirms guidance for 2025 financial year, highlighting transformation for future readiness

Annual General Meeting Dividend Transformation Technotrans 2025 Financial Year
PRESS RELEASE

published on 05/16/2025 at 13:00, 8 months 4 days ago

EIA Evaluation Process for the Penco Module Advances to Next Phase
Aclara Resources Inc. receives Second ICSARA for Penco Module EIA, planning response by Q3 2025. Company aims for high environmental standards

EIA Aclara Resources Inc. Environmental Standards Penco Module Second ICSARA
PRESS RELEASE

published on 05/16/2025 at 13:00, 8 months 4 days ago

Snipp Interactive Reports Financial Results for Q4 And Fiscal 2024, Announces Conference Call on May 20, 2025, And Management Changes
Snipp Interactive Inc. announces financial results for Q4-2024 and Fiscal 2024 under IFRS. Highlights include revenue growth and improved EBITDA. The company appoints a new CFO and plans to revoke FFCTO

Financial Results Snipp Interactive Inc. CFO IFRS Q4-2024
PRESS RELEASE

published on 05/16/2025 at 12:30, 8 months 4 days ago

NanoViricides, Inc. Has Filed its Quarterly Report: Broad-Spectrum Antiviral NV-387 To Combat MPox Pandemic in Africa - Phase II Clinical Trial Update, Also Readying to Combat Measles Outbreaks, and to Tackle Bird Flu
NanoViricides, Inc. reports filing Form 10-Q for quarter ending March 31, 2025 with SEC. Clears Phase II trial for NV-387 drug to treat MPox disease & explores Measles and Bird Flu treatments. Company has strong financials

NanoViricides NV-387 Financials Form 10-Q Phase II Trial
PRESS RELEASE

published on 05/16/2025 at 12:07, 8 months 4 days ago

IBU-tec advanced materials AG publishes final figures and Annual Report 2024 / EBITDA at the upper end of the forecast range
IBU-tec advanced materials AG publishes final figures and Annual Report 2024, with EBITDA at the upper end of the forecast range. Revenue increases to EUR 50.6 million in 2024

Financial Results Revenue Increase EBITDA Annual Report IBU-tec

Accesswire

Published on 01/20/2026 at 15:45, 25 minutes ago

Caldwell Announces New Sponsorship on Canada's Outstanding CEO of the Year(R)
Published on 01/20/2026 at 15:00, 1 hour 10 minutes ago

Pivotree Partners with OroCommerce to Deliver Unmatched B2B eCommerce Powered by Mastered Data
Published on 01/20/2026 at 14:30, 1 hour 40 minutes ago

Karbon-X Secures up to $25 Million in Strategic Financing to Accelerate Growth and Expand Global Climate Solutions Platform
Published on 01/20/2026 at 14:30, 1 hour 40 minutes ago

Core Silver Confirms Expansion of Laverdiere Porphyry by 280 Metres Through Drilling
Published on 01/20/2026 at 14:30, 1 hour 40 minutes ago

Innodata Awarded Prime Contract Position on U.S. Missile Defense Agency's IDIQ SHIELD Program

View all ACCESSWIRE

EQS Group

Published on 01/20/2026 at 16:00, 10 minutes ago

Orion Innovation Recognized in Connected Product Engineering Services, Q4 2025 Analyst Evaluation
Published on 01/20/2026 at 15:30, 39 minutes ago

swissnet Group Secures Major Hospitality Technology Project in Abu Dhabi
Published on 01/20/2026 at 15:29, 41 minutes ago

Issue of Equity
Published on 01/20/2026 at 15:11, 58 minutes ago

Voyageurs du Monde: Bilan semestriel au 31 décembre 2025 du contrat de liquidité contracté avec la société de Bourse Gilbert Dupont
Published on 01/20/2026 at 15:05, 1 hour 5 minutes ago

NoFap sues Pornhub under RICO Act, alleges collusion with academics on global disinformation campaign

Les Echos

Published on 01/20/2026 at 07:30, 8 hours 40 minutes ago

Gimv leidt een Series B investeringsronde van EUR 51 miljoen in Exciva voor verdere ontwikkeling van een innovatieve Alzheimerbehandeling
Published on 01/20/2026 at 07:30, 8 hours 40 minutes ago

Gimv leads € 51 million Series B investment round in Exciva to advance innovative Alzheimer’s therapy
Published on 01/20/2026 at 07:30, 8 hours 40 minutes ago

Gimv leads € 51 million Series B investment round in Exciva to advance innovative Alzheimer’s therapy
Published on 01/19/2026 at 17:45, 22 hours 25 minutes ago

Financial communication calendar 2026
Published on 01/19/2026 at 17:45, 22 hours 25 minutes ago

Calendrier de communication financière 2026

View all LES ECHOS COMFI WIRE